Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris

• Status: Completed
• Trial end date: 2016-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to evaluate a complete acne regimen consisting of a medication (Benzaknen® 5% Gel), and 2 cosmetic products Dermotivin® Soft Liquid soap and Cetaphil® Dermacontrol Moisturizer SPF30 in patients with acne.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Galderma; Galderma R&D
• Collaborator: Proinnovera GmbH
• Treatments: Benzoyl Peroxide

Criteria

Inclusion Criteria:

• Male or female subject of any ethnic background of 12 years or older.

• Subject with mild or moderate facial acne vulgaris defined as an Investigator Global Assessment (IGA) score at 2 or 3 on a 0-4 scale.

• Subject with any skin phototype according to T.B. Fitzpatrick skin phototype definitions.

Exclusion Criteria:

• Subject with severe acne (IGA>3) with nodules, cysts, scars or extra-facial lesions,

• Female subject who is pregnant, lactating or planning a pregnancy during the study,

• Subject susceptible to take a corticosteroid treatment during the study except inhaled or topic when needed to treat a condition outside the face,